Chapter 3 - The Ghost Company
By four o'clock that afternoon, the rain had turned into a torrential downpour that blanketed the Connecticut countryside in grey mist.
Adrian sat in the windowless sub-basement room of the Vale Family Office in downtown Stamford. Across the table sat Thomas Mercer, a retired forensic accountant who had served as Malcolm Vale’s chief auditor for thirty years before being quietly pushed into retirement five years ago.
Between them lay three thick, leather-bound ledgers that Thomas had pulled from his private home safe.
"Your father was a master of structural misdirection, Adrian," Thomas said, his hoarse voice barely audible over the hum of the server racks lining the wall. "When he bought the shipping lines in 1991, he created ninety-four separate holding entities in Nevis, Liechtenstein, and Delaware. But Kestrel... Kestrel wasn't a holding company."
Adrian leaned forward, his elbows resting on the cold steel table. "What was it?"
"It was an acquisition vehicle," Thomas said, tapping a yellowed paper ledger with a spotty finger. "In July 1994, Kestrel Corp incorporated in Delaware with a single initial capitalization of forty million dollars. Three days later, that entire sum was used to purchase a fifty-one percent controlling stake in a small, privately held biotechnology firm in Boston called Vance-Holloway Therapeutics."
Adrian frowned. "Vance-Holloway? I've never heard of them."
"You wouldn't have," Thomas said grimly. "Four months after your father bought the stake, the firm’s lead researcher—a woman named Dr. Evelyn Vance—was killed in an industrial accident at their Cambridge facility. The company surrendered its patents, liquidated its remaining assets to Kestrel Corp for pennies on the dollar, and dissolved."
Adrian felt a cold, prickling sensation spread down his spine.
Evelyn Vance.
"Did Dr. Vance have family?" Adrian asked, his voice barely above a whisper.
Thomas pulled a faded news clipping from the back of the folder. It showed a grainy black-and-white photograph of a smiling woman with dark, wavy hair and sharp, intelligent eyes. Standing beside her was a four-year-old girl with dark curls, holding a small plush bear.
The caption read: Tragic Loss: Dr. Evelyn Vance, 32, leaves behind husband and four-year-old daughter, Clara.
Adrian stared at the photograph. The woman’s face was hauntingly familiar. The shape of her mouth, the set of her jaw, the distinct, elegant arch of her eyebrows.
It was the face he had kissed goodbye at six o'clock that morning.
"Celeste," Adrian breathed, his throat tightening so hard he could barely draw air.
"Her birth name was Clara Vance," Thomas revealed quietly, looking at Adrian with deep, mournful pity. "When your father dissolved Vance-Holloway, he took every patent they held on synthetic blood-clotting factors—patents that later formed the core foundation of Vale Pharmaceutical’s nine-billion-dollar valuation. Her father died of alcoholism six years later. The girl was raised by state guardians in Massachusetts."
May you like
"She came to my firm four years ago," Adrian said, his voice trembling as the horrifying architecture of the lie assembled itself in his mind. "She applied for a junior analyst position. She had a degree from Columbia under the name Celeste Miller."
"She didn't come to your firm by accident, Adrian," Thomas said softly. "She spent fifteen years tracking down the paper trail your father buried. She didn't want a salary. She wanted what Malcolm Vale stole from her mother."
